Abstract 1324: A translational platform to design antibodies targeting triple negative breast cancer-specific antigens for cancer immunotherapy (2015)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1538-7445.am2015-1324
Publication URI: http://dx.doi.org/10.1158/1538-7445.am2015-1324
Type: Journal Article/Review
Parent Publication: Cancer Research
Issue: 15_Supplement